Skip to main content

American Academy of Pain Medicine (AAPM) 2014 Annual Meeting


Annals of Long-Term Care: Clinical Care and Aging. 2014;22(4):12-13.

March 6-9, 2014; Phoenix, AZ

Benzodiazepine Prescriptions Increasing in the United States

Ming-Chih Kao, MD, Stanford University, Cupertino, CA, and colleagues presented a poster that sought to shed light on benzodiazepine prescribing patterns in the United States, including whether these agents are being commonly prescribed to patients on opioids.

Read More>>


Pain Management Impeded by Opioid-Induced Constipation

Although the constipating effects of opioids are well described in the literature, it is unclear how opioid-induced constipation affects pain management for patients with chronic noncancer pain. To shed light on this issue, Catherine Datto, MD, MS, and researchers with AstraZeneca, presented a poster at the AAPM annual meeting that examined the effects of opioid-induced constipation in this population.

Read More>>


No Association Found Between Repeat Ketamine Infusions and Cognitive Dysfunction

Ketamine is generally used preoperatively as an anesthetic; however, it has also been used as a short-acting antidepressant in some elderly persons and to relieve severe neuropathic pain. As an N-methyl-D-aspartate (NMDA) antagonist, there has been some concern that repeated use of ketamine infusions can lead to cognitive dysfunction.

Read More>>

Back to Top